vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and KFORCE INC (KFRC). Click either name above to swap in a different company.

KFORCE INC is the larger business by last-quarter revenue ($330.4M vs $270.8M, roughly 1.2× HUTCHMED (China) Ltd). KFORCE INC runs the higher net margin — 2.4% vs 0.7%, a 1.7% gap on every dollar of revenue. On growth, KFORCE INC posted the faster year-over-year revenue change (0.1% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-7.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Kforce Inc. is a professional staffing and solutions firm headquartered in the United States. It provides skilled professional placements and specialized workforce solutions primarily across technology, finance & accounting, and healthcare segments, serving a wide range of mid-sized to large enterprise clients nationwide.

HCM vs KFRC — Head-to-Head

Bigger by revenue
KFRC
KFRC
1.2× larger
KFRC
$330.4M
$270.8M
HCM
Growing faster (revenue YoY)
KFRC
KFRC
+16.6% gap
KFRC
0.1%
-16.5%
HCM
Higher net margin
KFRC
KFRC
1.7% more per $
KFRC
2.4%
0.7%
HCM
More free cash flow
HCM
HCM
$10.8M more FCF
HCM
$3.4M
$-7.4M
KFRC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
KFRC
KFRC
Revenue
$270.8M
$330.4M
Net Profit
$2.0M
$7.9M
Gross Margin
37.7%
27.3%
Operating Margin
-13.2%
3.6%
Net Margin
0.7%
2.4%
Revenue YoY
-16.5%
0.1%
Net Profit YoY
-83.6%
-2.7%
EPS (diluted)
$0.00
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
KFRC
KFRC
Q1 26
$330.4M
Q4 25
$270.8M
$332.0M
Q3 25
$332.6M
Q2 25
$277.7M
$334.3M
Q1 25
$324.5M
$330.0M
Q4 24
$343.8M
Q3 24
$353.3M
Q2 24
$305.7M
$356.3M
Net Profit
HCM
HCM
KFRC
KFRC
Q1 26
$7.9M
Q4 25
$2.0M
$5.2M
Q3 25
$11.1M
Q2 25
$455.0M
$10.4M
Q1 25
$11.9M
$8.1M
Q4 24
$11.1M
Q3 24
$14.2M
Q2 24
$25.8M
$14.2M
Gross Margin
HCM
HCM
KFRC
KFRC
Q1 26
27.3%
Q4 25
37.7%
27.2%
Q3 25
27.7%
Q2 25
0.1%
27.1%
Q1 25
48.0%
26.7%
Q4 24
27.0%
Q3 24
27.9%
Q2 24
41.1%
27.8%
Operating Margin
HCM
HCM
KFRC
KFRC
Q1 26
3.6%
Q4 25
-13.2%
2.6%
Q3 25
4.5%
Q2 25
-1.3%
4.5%
Q1 25
-5.0%
3.5%
Q4 24
4.5%
Q3 24
5.3%
Q2 24
-9.0%
5.5%
Net Margin
HCM
HCM
KFRC
KFRC
Q1 26
2.4%
Q4 25
0.7%
1.6%
Q3 25
3.3%
Q2 25
163.8%
3.1%
Q1 25
3.7%
2.5%
Q4 24
3.2%
Q3 24
4.0%
Q2 24
8.4%
4.0%
EPS (diluted)
HCM
HCM
KFRC
KFRC
Q1 26
$0.46
Q4 25
$0.00
$0.29
Q3 25
$0.63
Q2 25
$0.52
$0.59
Q1 25
$0.01
$0.45
Q4 24
$0.60
Q3 24
$0.75
Q2 24
$0.03
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
KFRC
KFRC
Cash + ST InvestmentsLiquidity on hand
$1.4B
$1.3M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$117.4M
Total Assets
$1.8B
$384.8M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
KFRC
KFRC
Q1 26
$1.3M
Q4 25
$1.4B
$2.1M
Q3 25
$1.3M
Q2 25
$1.4B
$2.5M
Q1 25
$836.1M
$444.0K
Q4 24
$349.0K
Q3 24
$127.0K
Q2 24
$802.5M
$110.0K
Total Debt
HCM
HCM
KFRC
KFRC
Q1 26
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Stockholders' Equity
HCM
HCM
KFRC
KFRC
Q1 26
$117.4M
Q4 25
$1.2B
$124.6M
Q3 25
$132.1M
Q2 25
$1.2B
$134.4M
Q1 25
$759.9M
$138.0M
Q4 24
$154.6M
Q3 24
$167.4M
Q2 24
$740.1M
$166.6M
Total Assets
HCM
HCM
KFRC
KFRC
Q1 26
$384.8M
Q4 25
$1.8B
$365.6M
Q3 25
$374.2M
Q2 25
$1.8B
$373.6M
Q1 25
$1.3B
$368.2M
Q4 24
$357.8M
Q3 24
$369.9M
Q2 24
$1.3B
$362.7M
Debt / Equity
HCM
HCM
KFRC
KFRC
Q1 26
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
KFRC
KFRC
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
$-7.4M
FCF MarginFCF / Revenue
1.2%
-2.2%
Capex IntensityCapex / Revenue
1.8%
1.0%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$43.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
KFRC
KFRC
Q1 26
Q4 25
$8.2M
$19.7M
Q3 25
$23.3M
Q2 25
$-72.9M
$18.4M
Q1 25
$40.3M
$249.0K
Q4 24
$21.8M
Q3 24
$31.0M
Q2 24
$-39.8M
$20.9M
Free Cash Flow
HCM
HCM
KFRC
KFRC
Q1 26
$-7.4M
Q4 25
$3.4M
$16.7M
Q3 25
$19.8M
Q2 25
$-82.2M
$14.2M
Q1 25
$32.5M
$-3.9M
Q4 24
$20.9M
Q3 24
$27.5M
Q2 24
$-49.9M
$17.8M
FCF Margin
HCM
HCM
KFRC
KFRC
Q1 26
-2.2%
Q4 25
1.2%
5.0%
Q3 25
6.0%
Q2 25
-29.6%
4.3%
Q1 25
10.0%
-1.2%
Q4 24
6.1%
Q3 24
7.8%
Q2 24
-16.3%
5.0%
Capex Intensity
HCM
HCM
KFRC
KFRC
Q1 26
1.0%
Q4 25
1.8%
0.9%
Q3 25
1.1%
Q2 25
3.3%
1.2%
Q1 25
2.4%
1.3%
Q4 24
0.3%
Q3 24
1.0%
Q2 24
3.3%
0.9%
Cash Conversion
HCM
HCM
KFRC
KFRC
Q1 26
Q4 25
4.21×
3.82×
Q3 25
2.11×
Q2 25
-0.16×
1.76×
Q1 25
3.38×
0.03×
Q4 24
1.97×
Q3 24
2.18×
Q2 24
-1.54×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons